Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Athersys Inc
(NQ:
ATHX
)
1.510
USD
+0.020 (+1.34%)
Official Closing Price
/ Updated:
5:36 PM EST, Feb 22, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
335,900
Open
1.500
Bid (Size)
1.450 (10)
Ask (Size)
1.660 (30)
Prev. Close
1.490
Today's Range
1.485 - 1.520
52wk Range
1.290 - 3.090
Shares Outstanding
137,958,545
Dividend Yield
N/A
Performance
YTD
+2.03%
+2.03%
1 Month
-5.03%
-5.03%
3 Month
-24.50%
-24.50%
6 Month
-24.88%
-24.88%
1 Year
+9.42%
+9.42%
Top News
More News
Athersys to Host Year-End 2018 Financial Results Call
February 14, 2019
Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, March 14, 2019, and will host a conference call shortly thereafter at...
Read More
from
GlobeNewswire News Releases
Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem® Cell Therapy for Treatment of Acute Respiratory Distress Syndrome (ARDS)
January 23, 2019
Results Confirm Safety Profile and Demonstrate Meaningful Potential Benefits in Mortality, Ventilator-free Days and ICU-free Days
Read More
from
GlobeNewswire News Releases
More News
Read More
Healios Agrees to Make Payment to Extend Exclusive Period for Negotiating an Option for a License to Multistem® Therapy for Indications in China
December 17, 2018
from
GlobeNewswire News Releases
Athersys Reports Third Quarter 2018 Results
November 06, 2018
from
GlobeNewswire News Releases
Market Trends Toward New Normal in Crown, Athersys, CSX, Magellan Health, Spectrum Brands, and MGIC Investment — Emerging Consolidated Expectations, Analyst Ratings
October 29, 2018
from
GlobeNewswire News Releases
Athersys to Host Third Quarter Financial Results Call
October 09, 2018
from
GlobeNewswire News Releases
Increasing Number of Cancer Cases to Fuel the Global Cancer Immunotherapy Market Growth
October 05, 2018
from
PR Newswire
Athersys to Present at 2018 Cell & Gene Meeting on the Mesa
September 24, 2018
from
GlobeNewswire News Releases
Recent Analysis Shows Williams Partners, GameStop, Opko Health, Athersys, CSX, and Kratos Defense & Security Solutions Market Influences — Renewed Outlook, Key Drivers of Growth
August 14, 2018
from
GlobeNewswire News Releases
Athersys Reports Second Quarter 2018 Results
August 07, 2018
from
GlobeNewswire News Releases
The Growth of Stem Cell Applications are Contributing to the Cell Therapy Processing Market
August 06, 2018
from
PR Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.